Your browser doesn't support javascript.
loading
Feasibility and Safety of Oral Risperidone to Treat Prehospital Agitation.
Simpson, Nicholas S; Schin, Alexander M; Perlmutter, Michael C; Bunting, Alec J; Jones, Gregg A; Drone, Holly M; Merkle, Florian; Kummer, Timothy M; Driver, Brian E; Cole, Jon B; Robinson, Aaron E.
Afiliación
  • Simpson NS; Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota.
  • Schin AM; Hennepin EMS, Hennepin Healthcare, Minneapolis, Minnesota.
  • Perlmutter MC; Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota.
  • Bunting AJ; Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota.
  • Jones GA; Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota.
  • Drone HM; Hennepin EMS, Hennepin Healthcare, Minneapolis, Minnesota.
  • Merkle F; Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota.
  • Kummer TM; Hennepin EMS, Hennepin Healthcare, Minneapolis, Minnesota.
  • Driver BE; Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota.
  • Cole JB; Hennepin EMS, Hennepin Healthcare, Minneapolis, Minnesota.
  • Robinson AE; Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota.
Prehosp Emerg Care ; : 1-6, 2024 Jun 06.
Article en En | MEDLINE | ID: mdl-38808969
ABSTRACT

OBJECTIVE:

Agitation is a common prehospital problem and frequently presents without a clear etiology. Given the dynamic environment of the prehospital setting, there has historically been a varied approach to treating agitation with a heavy reliance on parenteral medications. Newer best practice guidelines recommend the incorporation of oral medications to treat patients experiencing agitation. Therefore, we evaluated the use of oral risperidone in a single system after a change in protocol occurred.

METHODS:

This was conducted as a retrospective chart review of an urban/suburban Emergency Medical Services system over the period of 8 months. The first day this medication was implemented throughout the service was included. Charts were included for selection if they included risperidone oral dissolving tablet (ODT) as a charted medication. The primary outcome was administration of additional medications to treat agitation. Exploratory outcome measures included acceptance of medication, documented injury to paramedics, documented injuries to patients, scene times, and adverse events that could possibly be linked to the medication.

RESULTS:

A total of 552 records were screened for inclusion. Risperidone was offered to 530 patients and accepted by 512 (96.6%). Of these 512 patients, the median age of included patients was 39 years old (IQR 29-52 years old) with a range of 18-89 years old. Rescue or additional medications for agitation were required in 9 (1.8%) cases. There were a total of 4 (0.8%) potential complications following administration of risperidone. There were no reported assaults with subsequent injuries to prehospital personnel or injuries sustained by patients reported in this study.

CONCLUSIONS:

Risperidone ODT was found to be a safe and effective medication to treat mild agitation in a large urban and suburban EMS system. The need for additional medications to treat agitation was rare, and there were no documented injuries to either patients or paramedics.

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Prehosp Emerg Care Asunto de la revista: MEDICINA DE EMERGENCIA Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Prehosp Emerg Care Asunto de la revista: MEDICINA DE EMERGENCIA Año: 2024 Tipo del documento: Article